TrialMolecular psychiatry2022

Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia.

Samantha V Abram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.